Convergence Investment Partners LLC Reduces Stock Position in HCA Healthcare, Inc. $HCA

Convergence Investment Partners LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 85.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 428 shares of the company’s stock after selling 2,526 shares during the period. Convergence Investment Partners LLC’s holdings in HCA Healthcare were worth $202,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. JSF Financial LLC raised its holdings in HCA Healthcare by 2.6% in the first quarter. JSF Financial LLC now owns 2,696 shares of the company’s stock worth $1,276,000 after purchasing an additional 68 shares in the last quarter. AlphaCentric Advisors LLC grew its holdings in HCA Healthcare by 185.1% in the first quarter. AlphaCentric Advisors LLC now owns 764 shares of the company’s stock worth $362,000 after purchasing an additional 496 shares during the last quarter. Decker Wealth Management LLC acquired a new position in HCA Healthcare during the 1st quarter valued at about $6,748,000. SEB Asset Management AB purchased a new position in shares of HCA Healthcare in the 1st quarter valued at approximately $75,534,000. Finally, Swiss National Bank grew its position in HCA Healthcare by 4.4% during the 1st quarter. Swiss National Bank now owns 468,760 shares of the company’s stock worth $221,836,000 after purchasing an additional 19,920 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Negative Sentiment: Multiple plaintiff law firms have launched investigations into HCA Healthcare over possible securities-law violations, increasing headline risk and investor uncertainty. HCA Healthcare, Inc. Investigated by the Portnoy Law Firm
• Negative Sentiment: Bragar Eagel & Squire is also investigating HCA on behalf of stockholders, adding to the cluster of legal inquiries that could pressure the shares. HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc.
• Negative Sentiment: Pomerantz LLP has opened a similar investigation, reinforcing concerns that the stock could face further legal scrutiny. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA
• Negative Sentiment: Kessler Topaz Meltzer & Check is likewise investigating HCA for potential federal securities-law violations, adding to the negative legal backdrop. NYSE: HCA Investigation: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. Investors to Contact the Firm
• Neutral Sentiment: HCA Florida Lake Monroe Hospital welcomed 29 new resident physicians, a routine operational update that is unlikely to move the stock on its own. HCA Florida Lake Monroe Hospital welcomes 29 new resident physicians
• Neutral Sentiment: HCA also highlighted leadership and project updates at several facilities, including promotions and new CMO appointments, which are more operational than market-moving. HCA Florida promotes CEO of 2 hospitals Arabinda Pani joins HCA Houston Healthcare Kingwood as CMO Think big: HCA rep. updates Rotary on Long Pt. ER and other projects
• Negative Sentiment: An HCA Georgia hospital paused most services amid flooding, which could create near-term operational disruption and reputational concerns. HCA Georgia hospital pauses most services amid flooding
• Neutral Sentiment: A story on HCA’s enterprise AI strategy was largely informational and highlights longer-term efficiency efforts rather than an immediate earnings catalyst. How HCA Healthcare built its enterprise AI strategy

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on HCA shares. TD Cowen cut their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research report on Monday, June 22nd. Cantor Fitzgerald dropped their target price on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research report on Tuesday, July 7th. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 7th. Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 14th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $483.45.

HCA Healthcare Stock Down 0.1%

HCA stock opened at $372.58 on Thursday. The firm has a market cap of $82.65 billion, a P/E ratio of 12.81, a PEG ratio of 1.26 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The company’s 50-day simple moving average is $388.88 and its 200-day simple moving average is $454.89.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the prior year, the company posted $6.45 EPS. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 29.19 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were paid a dividend of $0.78 per share. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.